Apple’s latest health project might just predict your future health risks

Pallavi Madhiraju- February 12, 2025 0

Apple has officially launched the Apple Health Study, marking a significant step towards redefining how technology can be used to predict, detect, and manage various ... Read More

Thermo Fisher Scientific launches global CorEvitas adolescent alopecia areata registry to advance real-world research

Pallavi Madhiraju- February 9, 2025 0

Thermo Fisher Scientific Inc., a global leader in serving science, has unveiled the international CorEvitas adolescent alopecia areata registry, marking a significant milestone in the ... Read More

CSL Limited’s AEGIS-II trial of CSL112 fails to meet primary endpoint in heart attack patients

Pallavi Madhiraju- February 12, 2024 0

CSL Limited (ASX:CSL; USOTC:CSLLY), a renowned global biotechnology leader, disclosed the top-line outcomes from its eagerly anticipated Phase 3 AEGIS-II trial. This pivotal study assessed ... Read More

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

pallavi123- March 30, 2021 0

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe ... Read More

Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment

pharmanewsdaily- November 3, 2018 0

Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib), a groundbreaking treatment for ... Read More